Vineeta Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vineeta Sharma has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Chethan Sampath
Department of Oral Diagnostic Sciences & Research, School of Dentistry Meharry Medical College, Nashville, United States, USA
1 shared publication - Gunaraj Dhungana
Department of Oral Diagnostic Sciences & Research, School of Dentistry, Meharry Medical College, Nashville, TN 37208, USA
1 shared publication Mohd Mabood Khan
Department of Medicine, Vanderbilt University Medical Center, Nashville, USA
1 shared publication- Olga Y. Korolkova
Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, TN 37208, USA
1 shared publication - Pandu R. Gangula
Department of ODS & Research, School of Dentistry, Meharry Medical College, Nashville, TN 37208, USA
1 shared publication
Latest Publications
- Open Access
Role of Nitric Oxide and Nrf2 to Counteract Vascular Endothelial Dysfunction Induced by Periodontal Pathogens Using HUVECs
Background: Polybacterial infections associated with periodontitis are increasingly linked to systemic vascular complications, yet the underlying endothelial mechanisms remain unclear. This study investigated how a consortium of red-complex bacteria (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola) and orange complex (Fusobacterium nucleatum) affects oxidative stress, inflammation, metabolism, and apoptosis in endothelial cells, and whether L-Sepiapterin [a tetrahydrobiopterin (BH4) precursor via salvage pathway] or bardoxolone methyl (CDDO-Me) [a potent nuclear factor erythroid 2-related factor 2 (Nrf2) activator)] could provide protection. Methods: Human umbilical vein endothelial cells (HUVECs) were infected for 12–72 h and treated with L-Sepiapterin or CDDO-Me. Nitric oxide (NO), BH4, and reactive oxygen species (ROS) levels were quantified, and mRNA expression of key genes regulating nitric oxide synthase activity, antioxidant defense, inflammation (TLR4/NF-κB, cytokines), metabolism (PI3K-AKT-PEA-15), and apoptosis (FAS–caspase pathway) was analyzed. Results: Infection markedly reduced NO and BH4, elevated ROS, activated TLR4/NF-κB and proinflammatory cytokines, disrupted PI3K/AKT signaling, and triggered endothelial apoptosis. Treatments with L-Sepiapterin and CDDO-Me restored NO bioavailability, reduced oxidative and inflammatory responses, normalized metabolic gene expression, and attenuated apoptosis, with CDDO-Me showing more promising effects. This study provides the mechanistic insight linking periodontal polybacterial infection to endothelial dysfunction and metabolic impairment such as diabetes, suggesting that redox-modulating strategies such as L-Sepiapterin and CDDO-Me may help prevent vascular damage associated with periodontal disease.
Open AccessRole of Nitric Oxide and Nrf2 to Counteract Vascular Endothelial Dysfunction Induced by Periodontal Pathogens Using HUVECs
Background: Polybacterial infections associated with periodontitis are increasingly linked to systemic vascular complications, yet the underlying endothelial mechanisms remain unclear. This study investigated how a consortium of red-complex bacteria (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola) and orange complex (Fusobacterium nucleatum) affects oxidative stress, inflammation, metabolism, and apoptosis in endothelial cells, and whether L-Sepiapterin [a tetrahydrobiopterin (BH4) precursor via salvage pathway] or bardoxolone methyl (CDDO-Me) [a potent nuclear factor erythroid 2-related factor 2 (Nrf2) activator)] could provide protection. Methods: Human umbilical vein endothelial cells (HUVECs) were infected for 12–72 h and treated with L-Sepiapterin or CDDO-Me. Nitric oxide (NO), BH4, and reactive oxygen species (ROS) levels were quantified, and mRNA expression of key genes regulating nitric oxide synthase activity, antioxidant defense, inflammation (TLR4/NF-κB, cytokines), metabolism (PI3K-AKT-PEA-15), and apoptosis (FAS–caspase pathway) was analyzed. Results: Infection markedly reduced NO and BH4, elevated ROS, activated TLR4/NF-κB and proinflammatory cytokines, disrupted PI3K/AKT signaling, and triggered endothelial apoptosis. Treatments with L-Sepiapterin and CDDO-Me restored NO bioavailability, reduced oxidative and inflammatory responses, normalized metabolic gene expression, and attenuated apoptosis, with CDDO-Me showing more promising effects. This study provides the mechanistic insight linking periodontal polybacterial infection to endothelial dysfunction and metabolic impairment such as diabetes, suggesting that redox-modulating strategies such as L-Sepiapterin and CDDO-Me may help prevent vascular damage associated with periodontal disease.
- 29 May 2025
- Published by Springer Nature in Current Microbiology
- Vol. 82 (7) , 1-14
Current Progress and Future Perspective of Chlamydia trachomatis Infection: A Rising Threat to Women Health
The most common sexually transmitted infection (STI) is caused by intracellular obligate bacteria Chlamydia trachomatis (CT) globally. Many Chlamydia infected women are asymptomatic or only experience minor signs, but others go on to develop salpingitis, endometritis, pelvic inflammatory disease (PID), ectopic pregnancy, and tubal factor infertility. It’s been linked to both the spread of HIV and new infections, and it’s suspected of playing a role in the emergence of cervical cancer. Clinically applicable rapid approaches for timely and precise identification of C. trachomatis infection would provide early treatment, hence reducing the risk of consequences. Traditional diagnostic methods Cell culture, direct immunofluorescence etc. are time-consuming but very sensitive assays for C. trachomatis infection. New and fast diagnostic method includes extraordinary optical transmission (EOT), loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), and microwave-accelerated metal-enhanced fluorescence (MAMEF) is more simple, rapid, sensitive, and cost-saving. This review provides fresh insight into our current understanding of C. trachomatis infection with emphasis on women’s health. We outline a crucial summary of risk factors, molecular and clinical picture, prevention, diagnosis of C. trachomatis infection. Further, this review provides various modes of treatment, including available vaccination against genital C. trachomatis infection and the future directions to combat this sexually transmitted infection.
- 29 May 2025
- Published by Springer Nature in Current Microbiology
- Vol. 82 (7) , 1-14
Current Progress and Future Perspective of Chlamydia trachomatis Infection: A Rising Threat to Women Health
The most common sexually transmitted infection (STI) is caused by intracellular obligate bacteria Chlamydia trachomatis (CT) globally. Many Chlamydia infected women are asymptomatic or only experience minor signs, but others go on to develop salpingitis, endometritis, pelvic inflammatory disease (PID), ectopic pregnancy, and tubal factor infertility. It’s been linked to both the spread of HIV and new infections, and it’s suspected of playing a role in the emergence of cervical cancer. Clinically applicable rapid approaches for timely and precise identification of C. trachomatis infection would provide early treatment, hence reducing the risk of consequences. Traditional diagnostic methods Cell culture, direct immunofluorescence etc. are time-consuming but very sensitive assays for C. trachomatis infection. New and fast diagnostic method includes extraordinary optical transmission (EOT), loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), and microwave-accelerated metal-enhanced fluorescence (MAMEF) is more simple, rapid, sensitive, and cost-saving. This review provides fresh insight into our current understanding of C. trachomatis infection with emphasis on women’s health. We outline a crucial summary of risk factors, molecular and clinical picture, prevention, diagnosis of C. trachomatis infection. Further, this review provides various modes of treatment, including available vaccination against genital C. trachomatis infection and the future directions to combat this sexually transmitted infection.